naion glp-1 news Small Risk from Therapy Not Yet Worth Drug Discontinuation, Experts Say Semaglutide use in patients with

So the FDA and pharmaceutical industry were really shy in investing in more obesity medications

However, clinical trials and real-world evidence consistently show that weight reduction with GLP-1RAs is accompanied by decrease in lean body mass, raising concern in patients already predisposed to muscle wasting and underscoring the need for integrated management strategies

You can prescribe it remotely for weight loss as long as you follow Floridas obesity treatment standards (more below)

So we see that our appetite signaling changes

As interest in GLP-1 medication grows, scammers are tricking consumers with fake alternatives

10.2337/db13-1440 [DOI] [PMC free article] [PubMed] [Google Scholar] Rinaman, L